| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC3850 |
| Trial ID | NCT06364852 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LY007 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | An Evaluation of LY007 Cell Injection for Recurrent/Refractory CD20 Was Positive Tolerability, Safety, and Efficacy of B-cell Non-Hodgkin Lymphoma in Open, Single-arm Stage I Clinical Research |
| Year | 2021 |
| Country | China |
| Company sponsor | Ruijin Hospital |
| Other ID(s) | LY007C1101 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||